Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Investigating the epi-miRNome: identification of epi-miRNAs using transfection experiments.

Reale E, Taverna D, Cantini L, Martignetti L, Osella M, De Pittà C, Virga F, Orso F, Caselle M.

Epigenomics. 2019 Nov;11(14):1581-1599. doi: 10.2217/epi-2019-0050. Epub 2019 Nov 6.

PMID:
31693439
2.

Independent Component Analysis for Unraveling the Complexity of Cancer Omics Datasets.

Sompairac N, Nazarov PV, Czerwinska U, Cantini L, Biton A, Molkenov A, Zhumadilov Z, Barillot E, Radvanyi F, Gorban A, Kairov U, Zinovyev A.

Int J Mol Sci. 2019 Sep 7;20(18). pii: E4414. doi: 10.3390/ijms20184414. Review.

3.

Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer Patients.

Cantini L, Pistelli M, Merloni F, Fontana A, Bertolini I, De Angelis C, Bastianelli L, Della Mora A, Santinelli A, Savini A, Maccaroni E, Diodati L, Falcone A, Berardi R.

Clin Breast Cancer. 2019 Jul 11. pii: S1526-8209(19)30081-3. doi: 10.1016/j.clbc.2019.06.008. [Epub ahead of print]

PMID:
31378534
4.

Molecular Inverse Comorbidity between Alzheimer's Disease and Lung Cancer: New Insights from Matrix Factorization.

Greco A, Sanchez Valle J, Pancaldi V, Baudot A, Barillot E, Caselle M, Valencia A, Zinovyev A, Cantini L.

Int J Mol Sci. 2019 Jun 26;20(13). pii: E3114. doi: 10.3390/ijms20133114.

5.

Assessing reproducibility of matrix factorization methods in independent transcriptomes.

Cantini L, Kairov U, de Reyniès A, Barillot E, Radvanyi F, Zinovyev A.

Bioinformatics. 2019 Nov 1;35(21):4307-4313. doi: 10.1093/bioinformatics/btz225.

6.

Hope4Genes: a Hopfield-like class prediction algorithm for transcriptomic data.

Cantini L, Caselle M.

Sci Rep. 2019 Jan 23;9(1):337. doi: 10.1038/s41598-018-36744-y.

7.

Identification of microRNA clusters cooperatively acting on epithelial to mesenchymal transition in triple negative breast cancer.

Cantini L, Bertoli G, Cava C, Dubois T, Zinovyev A, Caselle M, Castiglioni I, Barillot E, Martignetti L.

Nucleic Acids Res. 2019 Mar 18;47(5):2205-2215. doi: 10.1093/nar/gkz016.

8.

Optimal management of resected gastric cancer.

Giampieri R, Del Prete M, Cantini L, Baleani MG, Bittoni A, Maccaroni E, Berardi R.

Cancer Manag Res. 2018 Jun 21;10:1605-1618. doi: 10.2147/CMAR.S151552. eCollection 2018. Review.

9.

Long-responders to anti-HER2 therapies: A case report and review of the literature.

Cantini L, Pistelli M, Savini A, Bastianelli L, Della Mora A, Merloni F, Burattini M, Berardi R.

Mol Clin Oncol. 2018 Jan;8(1):147-152. doi: 10.3892/mco.2017.1495. Epub 2017 Nov 8.

10.

Are liver nested stromal epithelial tumors always low aggressive?

Meletani T, Cantini L, Lanese A, Nicolini D, Cimadamore A, Agostini A, Ricci G, Antognoli S, Mandolesi A, Guido M, Alaggio R, Giuseppetti GM, Scarpelli M, Vivarelli M, Berardi R.

World J Gastroenterol. 2017 Dec 14;23(46):8248-8255. doi: 10.3748/wjg.v23.i46.8248.

11.

Classification of gene signatures for their information value and functional redundancy.

Cantini L, Calzone L, Martignetti L, Rydenfelt M, Blüthgen N, Barillot E, Zinovyev A.

NPJ Syst Biol Appl. 2017 Dec 19;4:2. doi: 10.1038/s41540-017-0038-8. eCollection 2018.

12.

Determining the optimal number of independent components for reproducible transcriptomic data analysis.

Kairov U, Cantini L, Greco A, Molkenov A, Czerwinska U, Barillot E, Zinovyev A.

BMC Genomics. 2017 Sep 11;18(1):712. doi: 10.1186/s12864-017-4112-9.

13.

Dual peptide-mediated targeted delivery of bioactive siRNAs to oral cancer cells in vivo.

Alexander-Bryant AA, Zhang H, Attaway CC, Pugh W, Eggart L, Sansevere RM, Andino LM, Dinh L, Cantini LP, Jakymiw A.

Oral Oncol. 2017 Sep;72:123-131. doi: 10.1016/j.oraloncology.2017.07.004. Epub 2017 Jul 21.

14.

A review of computational approaches detecting microRNAs involved in cancer.

Cantini L, Caselle M, Forget A, Zinovyev A, Barillot E, Martignetti L.

Front Biosci (Landmark Ed). 2017 Jun 1;22:1774-1791. Review.

15.

Detection of gene communities in multi-networks reveals cancer drivers.

Cantini L, Medico E, Fortunato S, Caselle M.

Sci Rep. 2015 Dec 7;5:17386. doi: 10.1038/srep17386.

16.

MicroRNA-mRNA interactions underlying colorectal cancer molecular subtypes.

Cantini L, Isella C, Petti C, Picco G, Chiola S, Ficarra E, Caselle M, Medico E.

Nat Commun. 2015 Nov 17;6:8878. doi: 10.1038/ncomms9878.

17.

Identification and characterization of Dicer1e, a Dicer1 protein variant, in oral cancer cells.

Cantini LP, Andino LM, Attaway CC, Butler B, Dumitriu A, Blackshaw A, Jakymiw A.

Mol Cancer. 2014 Aug 13;13:190. doi: 10.1186/1476-4598-13-190.

18.

Linear noise approximation for stochastic oscillations of intracellular calcium.

Cantini L, Cianci C, Fanelli D, Massi E, Barletti L.

J Theor Biol. 2014 May 21;349:92-9. doi: 10.1016/j.jtbi.2014.01.035. Epub 2014 Feb 3.

PMID:
24503287
19.

Stochastic amplification of spatial modes in a system with one diffusing species.

Cantini L, Cianci C, Fanelli D, Massi E, Barletti L, Asllani M.

J Math Biol. 2014 Dec;69(6-7):1585-608. doi: 10.1007/s00285-013-0743-x. Epub 2013 Dec 14.

PMID:
24337716
20.

Fusogenic-oligoarginine peptide-mediated delivery of siRNAs targeting the CIP2A oncogene into oral cancer cells.

Cantini L, Attaway CC, Butler B, Andino LM, Sokolosky ML, Jakymiw A.

PLoS One. 2013 Sep 3;8(9):e73348. doi: 10.1371/journal.pone.0073348. eCollection 2013.

21.

GSK3β inhibition blocks melanoma cell/host interactions by downregulating N-cadherin expression and decreasing FAK phosphorylation.

John JK, Paraiso KH, Rebecca VW, Cantini LP, Abel EV, Pagano N, Meggers E, Mathew R, Krepler C, Izumi V, Fang B, Koomen JM, Messina JL, Herlyn M, Smalley KS.

J Invest Dermatol. 2012 Dec;132(12):2818-27. doi: 10.1038/jid.2012.237. Epub 2012 Jul 19.

22.

Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy.

Paraiso KH, Fedorenko IV, Cantini LP, Munko AC, Hall M, Sondak VK, Messina JL, Flaherty KT, Smalley KS.

Br J Cancer. 2010 Jun 8;102(12):1724-30. doi: 10.1038/sj.bjc.6605714.

23.

The future of targeted therapy approaches in melanoma.

Cantini LP, Meier F, Sondak VK, Smalley KS.

Expert Opin Drug Discov. 2009 Apr;4(4):445-56. doi: 10.1517/17460440902828298.

PMID:
23485043
24.

Profibrotic role of myostatin in Peyronie's disease.

Cantini LP, Ferrini MG, Vernet D, Magee TR, Qian A, Gelfand RA, Rajfer J, Gonzalez-Cadavid NF.

J Sex Med. 2008 Jul;5(7):1607-22. doi: 10.1111/j.1743-6109.2008.00847.x.

PMID:
18422491
25.

Antisense and short hairpin RNA (shRNA) constructs targeting PIN (Protein Inhibitor of NOS) ameliorate aging-related erectile dysfunction in the rat.

Magee TR, Kovanecz I, Davila HH, Ferrini MG, Cantini L, Vernet D, Zuniga FI, Rajfer J, Gonzalez-Cadavid NF.

J Sex Med. 2007 May;4(3):633-643. doi: 10.1111/j.1743-6109.2007.00459.x. Epub 2007 Apr 13.

PMID:
17433082
26.

Myostatin short interfering hairpin RNA gene transfer increases skeletal muscle mass.

Magee TR, Artaza JN, Ferrini MG, Vernet D, Zuniga FI, Cantini L, Reisz-Porszasz S, Rajfer J, Gonzalez-Cadavid NF.

J Gene Med. 2006 Sep;8(9):1171-81.

PMID:
16810717
27.

Evidence that osteogenic progenitor cells in the human tunica albuginea may originate from stem cells: implications for peyronie disease.

Vernet D, Nolazco G, Cantini L, Magee TR, Qian A, Rajfer J, Gonzalez-Cadavid NF.

Biol Reprod. 2005 Dec;73(6):1199-210. Epub 2005 Aug 10.

PMID:
16093362
28.

Correlation between strand asymmetry and phylogeny in mitochondrial DNA.

Barral P J, Cantini L, Hasmy A, Jiménez J, Marcano A.

J Theor Biol. 2005 Oct 21;236(4):422-6.

PMID:
15927203
29.

Assessment of inhaled BDP-dose dependency of exhaled nitric oxide and local and serum eosinophilic markers in steroids-naive nonatopic asthmatics.

Dal Negro R, Micheletto C, Tognella S, Turco P, Rossetti A, Cantini L.

Allergy. 2003 Oct;58(10):1018-22.

PMID:
14510719
30.

Comparison of once- versus twice-daily use of beclomethasone dipropionate aqueous nasal spray in the treatment of allergic and non-allergic chronic rhinosinusitis.

Giger R, Pasche P, Cheseaux C, Cantini L, Rossetti A, Landis BN, Lacroix JS.

Eur Arch Otorhinolaryngol. 2003 Mar;260(3):135-40. Epub 2002 Nov 6.

PMID:
12687385
31.

Effects on lung function, symptoms, and bronchial hyperreactivity of low-dose inhaled beclomethasone dipropionate given with HFA-134a or CFC propellant.

Woodcock A, Williams A, Batty L, Masterson C, Rossetti A, Cantini L.

J Aerosol Med. 2002 Winter;15(4):407-14.

PMID:
12581507
32.

A new HFA-134a propellant in the administration of inhaled BDP via the Jet spacer: controlled clinical trial vs the conventional CFC.

Vondra V, Sladek K, Kotasová J, Terl M, Rossetti A, Cantini L.

Respir Med. 2002 Oct;96(10):784-9.

33.

Equivalent efficacy and safety of a new HFA-134a formulation of BDP compared with the conventional CFC in adult asthmatics.

Anderson PB, Langley SJ, Mooney P, Jones J, Addlestone R, Rossetti A, Cantini L.

J Investig Allergol Clin Immunol. 2002;12(2):107-13.

PMID:
12371526
34.
35.

Evidence of adequacy of the performance of the Pulvinal by measuring through-device peak inspiratory flow rate in severe airways obstruction in adults and children.

Negro RD, Micheletto C, Tognella S, Clayton N, Cantini L, Woodcock A.

J Aerosol Med. 2001 Fall;14(3):343-9.

PMID:
11693846
36.

Treating asthma in children with beclomethasone dipropionate: Pulvinal versus Diskhaler.

De Benedictis FM, Boner A, Cavagni G, Caffarelli C, Ferraro L, Cantini L.

J Aerosol Med. 2000 Spring;13(1):35-41.

PMID:
10947322
37.

Effect of inhaled beclomethasone dipropionate and budesonide dry powder on pulmonary function and serum eosinophil cationic protein in adult asthmatics.

Dal Negro R, Micheletto C, Tognella S, Mauroner L, Burti E, Turco P, Pomari C, Cantini L.

J Investig Allergol Clin Immunol. 1999 Jul-Aug;9(4):241-7.

PMID:
10513351
38.

Inhaled beclomethasone dipropionate downregulates CD4 and CD8 T-lymphocyte activation in peripheral blood of patients with asthma.

Majori M, Piccoli ML, Bertacco S, Cuomo A, Cantini L, Pesci A.

J Allergy Clin Immunol. 1997 Sep;100(3):379-82.

PMID:
9314351
39.

Inhaled beclomethasone dipropionate administered through a new spacer device: a controlled clinical study.

Vecchiet L, Pieralisi G, Ambrosi L, Di Lorenzo L, Cantini L.

Adv Ther. 1996 Nov-Dec;13(6):335-46.

PMID:
10165114
40.

A new spacer device for administration of inhaled salbutamol: use in elderly asthmatics.

Donateo L, Gerardi R, Cantini L.

Adv Ther. 1996 Sep-Oct;13(5):292-300.

PMID:
10163928
41.

Beclomethasone dipropionate given to adult asthmatics through a new spacer device: effects of high-dose administration.

Girbino G, Lauriello G, Andó F, Cantini L.

Adv Ther. 1996 Jul-Aug;13(4):220-9.

PMID:
10163482
42.

Efficacy and tolerability of brodimoprim at two different dosage schedules in the treatment of acute uncomplicated bacterial cystitis: comparative study vs. pefloxacin.

Cosmi EV, Cantini L, Monici Preti PA, Di Renzo GC, Abate F, Balsotti G, Carlomagno G, Cirese E, Indraccolo R, La Sala GB, Mearini L, Minozzi M, Scarpello F.

Eur J Obstet Gynecol Reprod Biol. 1996 Feb;64(2):207-11.

PMID:
8820004
43.

Severity grading of childhood poisoning: the Multicentre Study of Poisoning in Children (MSPC) score.

Marchi AG, Bet N, Peisino MG, Vietti-Ramus M, Raspino M, Di Pietro P, Bernini G, Cantini L, Chiandetti L, Da Dalt L, et al.

J Toxicol Clin Toxicol. 1995;33(3):223-31.

PMID:
7760446
44.
45.

Platelet and endothelial response with trapidil in patients with peripheral obliterative arteriopathy.

Bonfardeci G, Cimminiello C, Cantini L, Arpaia G, Aloisio M, Pozzi F.

Int Angiol. 1994 Dec;13(4):339-42.

PMID:
7790757
46.

The trapidil restenosis trial (STARC study): background, methods and clinical characteristics of the patient population.

Maresta A, Balducelli M, Cantini L, Casari A, Chioin R, Fontanelli A, Monici Preti PA, Repetto S, Raffaghello S.

Clin Trials Metaanal. 1994 Apr;29(1):31-40.

PMID:
10150183
47.

Efficacy and tolerability of brodimoprim in bacterial otitis media in children. Controlled study versus cefaclor.

Galetti G, Martini A, Bergamini G, Dallari S, Ghidini A, Mazzoli M, Cantini L, Monici Preti PA.

J Chemother. 1993 Dec;5(6):551-5.

PMID:
8195856

Supplemental Content

Loading ...
Support Center